ACE and neoplasm: Nevertheless, aspirin and beta-blockers have advanced to randomized clinical trials (RCTs) to confirm their anti-tumor effects, while findings have been inconsistent with regard to cancer and ACE inhibitors, ARBs, cardiac glycosides or statins.